FDA Licenses New Hemophilia Treatment (Medical News Today)
The U.S. Food and Drug Administration licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.

FDA Rejection Of Avastin For Breast Cancer Therapy Would Be 'Unscientific, Unethical,' Editorial Says (Medical News Today)
It would "not only be unscientific but unethical" for FDA to reject Genentech's colon and lung cancer treatment Avastin for use as metastatic breast cancer treatment, a Wall Street Journal editorial says (Wall Street Journal, 2/21). FDA is scheduled to decide Saturday whether to approve Avastin for treatment of metastatic breast cancer.